Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.66 USD | +3.10% | -10.74% | +98.51% |
Mar. 20 | Transcript : Trevi Therapeutics, Inc., Q4 2023 Earnings Call, Mar 20, 2024 | |
Mar. 20 | Trevi Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+98.51% | 178M | |
-3.24% | 102B | |
+2.45% | 96.84B | |
+0.17% | 21.48B | |
-18.46% | 20.82B | |
-7.45% | 18.6B | |
-40.70% | 16.81B | |
-25.06% | 13.78B | |
+0.63% | 13.4B | |
+22.60% | 11.06B |
- Stock Market
- Equities
- TRVI Stock
- News Trevi Therapeutics, Inc.
- Trevi Therapeutics : Enters Agreement With Healthcare-Focused Institutional Investor to Offer Common Stock, Warrants